Cardiology: 150 CME educational programs available now

Thrombosis

May 14, 2012 14:02 EDT

Drs Kakkar, Fox, Verheugt, and Büller present the latest clinical trial data on novel, oral anticoagulants across the spectrum of thromboembolic diseases.

Thrombosis

Tailoring Anticoagulation Therapy to Patient Needs: Evaluating Stroke Risk in Atrial Fibrillation

May 7, 2012 10:07 EDT

Drs. Camm and Bode discuss the practicalities of using novel anticoagulants for the prevention of AF-related stroke.

Thrombosis

Putting the AF-Stroke Prevention Trials Into Perspective: Looking at the Big Picture

Apr 30, 2012 10:38 EDT

Drs. Turpie, Califf, Granger, and Wallentin discuss how novel oral anticoagulants are being used in the prevention of AF-related stroke.

Thrombosis

Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS

Apr 24, 2012 10:22 EDT

Drs. Gibson, Verheugt, Alexander, and Ohman discuss the evidence for using novel oral anticoagulants in patients following an ACS.

Thrombosis

All About Pulmonary Embolism: Assessing Risk, Managing Patients

Apr 19, 2012 13:53 EDT

Drs. Goldhaber, Büller, and Konstantinides discuss clinical-trial results of a new oral therapy for patients with PE.

Acute Coronary Syndromes

Oral Anticoagulant Therapy in Thromboembolic Disease: The Key Questions

Mar 16, 2012 14:12 EDT

Drs. Bauer, Weitz, Mega, Spyropoulos, and Turpie discuss important clinical questions regarding the care of patients at risk for venous or arterial thromboembolic events

Thrombosis

New Treatment Options in the Prevention of AF-Related Stroke

Jan 24, 2012 14:30 EST

Individualizing thromboprophylaxis in patients with AF and the role of novel oral anticoagulants are highlighted in cases presented by Dr. Lip.

Thrombosis

Breaking Down Symptomatic DVT: Treatment Gaps in Recurrent Disease

Jan 23, 2012 10:50 EST

Novel oral anticoagulants hold the promise of simplifying the treatment of acute and recurrent VTE; Drs. Turpie, Agnelli, and Cohen discuss recent findings.

Thrombosis

Case Scenarios in AF-Related Stroke: Connecting the Dots Between Clinical Trials and Patient Care

2 COMMENTS - Dec 28, 2011 10:48 EST

Drs. Fox, Califf, Connolly, and Patel review key clinical-trial data of novel oral anticoagulants and use real-world case scenarios to discuss strategies on how to best manage patients with AF and other comorbidities.

Thrombosis

Prevention and Treatment of Venous and Arterial Thromboembolic Disease: Revisiting the Evidence Base-Stroke Prevention in AF

Dec 15, 2011 14:06 EST

Drs. Ortel, Ezekowitz, Gibson, Giugliano, Granger, Hylek, Lip, and Patel review trial data exploring pharmacotherapies to improve care in patients with AF who are at risk of stroke.

Thrombosis

A New Age in Anticoagulation: Rethinking Secondary Prevention in ACS

9 COMMENTS - Dec 8, 2011 08:37 EST

Drs. Bode, Verheugt, and Fox present their take on new trial data from AHA 2011 and what it will mean for patients after ACS.

Thrombosis

Prevention and Treatment of Venous and Arterial Thromboembolic Disease: Revisiting the Evidence Base-VTE Treatment

Nov 30, 2011 14:00 EST

Address practice gaps and evaluate evidence-based data regarding the safety and efficacy of existing and novel pharmacotherapies and pharmacomechanical techniques in VTE.

Thrombosis

Secondary Stroke Prevention in AF: Impact and Burden on Practice and Healthcare Systems

2 COMMENTS - Sep 28, 2011 13:39 EDT

Drs. Eikelboom, Bode, and Hankey discuss how novel anticoagulants will improve outcomes for patients with AF who have had a stroke.

Thrombosis

A New Era in the Management of Atrial Fibrillation: An Update on Oral Anticoagulation

7 COMMENTS - Sep 27, 2011 14:00 EDT

Join our experts, Drs. Braunwald, Wallentin, Califf, Alexander, Giugliano, and Turpie, as they discuss perspectives from ESC 2011 on improving standard of care for patients with atrial fibrillation at risk for stroke.

Thrombosis

Addressing Gaps in Patient Care: The Importance of Anticoagulation in Secondary Prevention

1 COMMENT - Sep 26, 2011 16:00 EDT

Join Dr. Bhatt and an international panel of experts Drs. Steg, Bode, and Fox in an interactive town hall, filmed at the recent ESC Congress in Paris.

Thrombosis

Prevention and Treatment of Thromboembolic Disease: Revisiting the Evidence Base-Surgical Thromboprophylaxis

Sep 26, 2011 13:42 EDT

Discuss evidence-based data and address an array of issues involving prevention and treatment of venous thromboembolism in patients in many settings and at various levels of risk.

Thrombosis

VTE Treatment Simplified: Thoughts on Improving Patient Care

Aug 23, 2011 13:00 EDT

Drs. Turpie, Büller, and Weitz discuss late-breaking data on novel oral anticoagulants for the treatment of VTE presented at ISTH in Kyoto, Japan.

AF-Related Stroke: Evaluating the Clinical and Economic Impact of New Oral Anticoagulants

Thrombosis

1 COMMENT - Jul 20, 2011 14:40 EDT

Drs. Hacke, Diener, Hennerici, and Norrving discuss new strategies for the secondary prevention of AF-related stroke.

Thrombosis

Combination Therapy or Triple Antiplatelet Therapy?

Jun 23, 2011 15:05 EDT

Join Drs. Bassand and Huber as they discuss the pros and cons of more intense platelet inhibition in patients post-ACS.

Acute Coronary Syndromes

Defining the Future of Oral Anticoagulant Therapy: Across the Spectrum of Thromboembolic Disease

May 25, 2011 10:38 EDT

Drs. Becker and Weitz lead a discussion with Drs. Agnelli, Ezekowitz, Heit, and Mahaffey on the envisioned improvements in care of patients with thromboembolic disease

Thrombosis

Thinking Beyond Platelet Inhibition: Oral Anticoagulation for Secondary Prevention in ACS

May 6, 2011 14:42 EDT

When dual antiplatelet therapy fails, what are the options? Dr. Verheugt discusses the evolving concepts in secondary prevention of ACS in this clinical update.

Thrombosis

Coagulation Simplified

Jul 29, 2010 16:11 EDT

With a greater understanding of the mechanisms of coagulation, anticoagulant therapy is moving toward targeted therapy with the promise of improved patient outcomes. But are we there yet? Dr Jeffrey Weitz presents a clinical update.

Thrombosis

Trial Designs in AF-Related Stroke: How Do They Relate to Real-World Practice?

Jul 19, 2010 13:51 EDT

Join Drs. Hacke and Diener as they give a neurologist's perspective on the potential impact of novel anticoagulants on the risk for stroke in patients with AF.